BA Kroner - Diabetes Spectrum, 2002 - Am Diabetes Assoc The Food and Drug Administration approves about 25 new drug entities each year,
and new interactions are also reported for drugs already in use. Only recently
have serious drug interactions been responsible for the withdrawal of drugs ... Cited by 2 - Related articles - BL Direct - All 3 versions
JR White Jr, RK Campbell - The Diabetes Educator - ncbi.nlm.nih.gov 1: Diabetes Educ. 1995 Jul-Aug;21(4):283, 285-6, 289. Drug/drug and
drug/disease interactions and diabetes. White JR Jr, Campbell RK. ... Cited by 7 - Related articles
MC Perault, E Griesemann, S Bouquet, J … - Therapeutic drug monitoring, 1989 - ncbi.nlm.nih.gov The effect of viloxazine on the pharmacokinetics of theophylline was studied in
eight healthy volunteers. Theophylline 200 mg/day (théophylline Bruneau 100 mg
tablets) was administered on day 1; after a 3-day washout period, ... Cited by 3 - Related articles - All 3 versions
G Slama, F Elgrably, A Sola, J Mbemba, E … - Diabetes and Metabolism, 2006 - Elsevier Postprandial hyperglycaemia is a phenomenon often neglected by patients as well
as doctors. While patients only voluntarily measure morning and preprandial
capillary glycaemia, physicians do not encourage the measurement of ... Cited by 3 - Related articles - BL Direct - All 3 versions
R Dahlqvist, E Steiner, Y Koike, C von Bahr, M … - Therapeutic drug monitoring, 1989 - journals.lww.com Therapeutic Drug Monitoring 11:408-410 € 1989 Raven Press. Ltd.. New York
Induction of Theophylline Metabolism by Pentobarbital R. Dahlqvist, E. Steiner,
Y. Koike, С. von Bahr, M. Lind, and *B. Billing Departments of Clinical ... Cited by 3 - Related articles - All 5 versions
[CITATION] The interaction of phenytoin and theophylline
JW Taylor, L Hendeles, M Weinberger, LW … - Drug. Intell. Clin. Pharm, 1980 Cited by 3 - Related articles
JE Aikens, DW Perkins, JD Piette, B Lipton - Diabetic Medicine, 2008 - interscience.wiley.com Aims Although depression has weak associations with several Type 2 diabetes
mellitus (DM) outcomes, it is possible that these associations are concentrated
within certain patient subgroups that are more vulnerable to their effects. ... Cited by 3 - Related articles - All 4 versions
- ►nih.gov [PDF] SA Rae, IA Williams, J English, EM Baylis - British Journal of Clinical Pharmacology, 1982 - pubmedcentral.nih.gov Eleven patients with stable rheumatoid disease (RD) who were receiving regular
corticosteroid therapy (CS) were investigated to discover the effect on plasma
prednisolone levels of additional therapy with the non-steroidal anti- ... Cited by 4 - Related articles - All 3 versions
[CITATION] Do corticosteroids really cause upper GI bleeding
JL Carson, BL Strom, R Schinnar, E Sim, G … - J Clin Res Drug Develop, 1987 Cited by 4 - Related articles
SJ Sklar, JC Wagner - Drug intelligence & clinical pharmacy, 1985 - ncbi.nlm.nih.gov This report describes two cases in which theophylline clearance accelerated
markedly with concomitant phenytoin administration. Maximum calculated
theophylline clearance ranged from 2 1/2 to 3 1/2 times baseline. Onset of ... Cited by 4 - Related articles - All 3 versions
